Evidence map›Paper›PMID 33093783›Full record

Trial reportSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2020

The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study.

Monique Wapenaar, Elisabeth Bendstrup, Maria Molina-Molina, Maarten K N Stessel, Jasmina Huremovic, Eric W Bakker, Isabella Kardys, Joachim G J V Aerts, Marlies S Wijsenbeek

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pulmonary rehabilitation for interstitial lung disease.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Monique WapenaarDepartment of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Elisabeth BendstrupDepartment of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus.
Maria Molina-MolinaILD Unit, Hospital de Bellvitge-IDIBELL, University of Barcelona, Spain.
Maarten K N StesselDepartment of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark.
Jasmina HuremovicDepartment of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark.
Eric W BakkerDivision Clinical Methods and Public Health, Academic Medical Center, University of Amsterdam, the Netherlands.
Isabella KardysDepartment of Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Joachim G J V AertsDepartment of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Marlies S WijsenbeekDepartment of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Erasmus MC · NLAalborg University Hospital · DKAarhus University Hospital · DKAcademic Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by progressive loss of pulmonary function and exercise capacity, leading to loss of quality of life and often social isolation. A new walking aid, the walk-bike, showed an improvement in exercise performance in COPD patients. Aims of this pilot study were to evaluate feasibility of a homebased walk-bike intervention study in IPF patients and to explore the effect of the walk-bike on quality of life (QoL) and exercise capacity. Twenty-three patients with IPF were included in a randomized multicenter crossover study with 8 weeks of standard care and 8 weeks of walk-bike use at home. Ten patients completed both study phases. Study barriers included reluctance to participate and external factors (e.g. weather and road conditions) that hampered adherence. Patients' satisfaction and experience with the walk-bike varied greatly. After training with the walk-bike, health-related QoL (St. George's Respiratory and King's Brief Interstitial Lung Disease questionnaires) demonstrated a tendency towards improvement, exercise capacity did not. A clinically important difference was found between 6-minute walk test with the walk-bike and the standard test; median (range) respectively 602 m (358-684) and 486 m (382-510). Conclusions: Due to practical barriers a larger study with the walk-bike in patients with IPF seems not feasible. Individual patients may benefit from the use of a walk-bike as it improved action radius and showed a tendency towards improvement in QoL. No effect on exercise capacity was observed.

Indexed as

Dependent AmbulationExercise ToleranceMobility LimitationQuality of LifeWalkingAgedAged, 80 and overCross-Over StudiesEquipment DesignExercise TherapyFeasibility StudiesFemaleHumansIdiopathic Pulmonary FibrosisMaleMiddle AgedExercise capacityExercise trainingHome-based trainingIdiopathic Pulmonary FibrosisQuality of Life

Identifiers

PMID33093783
PMCPMC7569562
OpenAlexW3090227423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.